IGC Pharma (IGC) Times Interest Earned (2010 - 2025)
IGC Pharma (IGC) posted quarterly Times Interest Earned of -$36.7 for Q3 2025, down 146.03% year-over-year from $79.72 in Q3 2024, and down 52.18% quarter-over-quarter from -$24.11 in Q2 2025.
IGC Pharma (IGC) Times Interest Earned (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Times Interest Earned for 16 consecutive years, with -$36.7 the latest figure, recorded in Q3 2025.
- In Q3 2025, Times Interest Earned fell 146.03% year-over-year to -$36.7; the TTM figure through Sep 2025 stood at -$102.47 (down 29.68% YoY), while the FY2026 annual figure was -$2.63, up 84.91% from the prior year.
- Times Interest Earned declined to -$36.7 in Q3 2025 per IGC's latest filing, from -$24.11 in the prior quarter.
- Across five years, Times Interest Earned topped out at $3.98 in Q1 2021 and bottomed at -$75.66 in Q2 2021.
- Historically, Times Interest Earned has averaged -$23.98 across 5 years, with a median of -$20.48 in 2024.
- Annual changes were most pronounced in 2021 — Times Interest Earned jumped 100.33% — and 2022, when it plunged 1645.51%.
- IGC Pharma's Times Interest Earned stood at -$4.83 in 2021, then slumped by 520.84% to -$29.97 in 2022, then advanced by 7.39% to -$27.76 in 2023, then rose by 14.36% to -$23.77 in 2024, then plunged by 54.37% to -$36.7 in 2025.
- Business Quant data shows IGC's Times Interest Earned at -$36.7 in Q3 2025, -$24.11 in Q2 2025, and -$11.21 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -36.70 |
| Jun 30, 2025 | -24.11 |
| Mar 31, 2025 | -11.21 |
| Dec 31, 2024 | -23.77 |
| Sep 30, 2024 | -14.92 |
| Jun 30, 2024 | -20.48 |
| Mar 31, 2024 | -15.96 |
| Dec 31, 2023 | -27.76 |
| Sep 30, 2023 | -23.28 |
| Jun 30, 2023 | -20.18 |
| Mar 31, 2023 | -35.46 |
| Dec 31, 2022 | -29.97 |
| Sep 30, 2022 | -18.99 |
| Jun 30, 2022 | -6.46 |
| Mar 31, 2022 | -61.45 |
| Dec 31, 2021 | -4.83 |
| Sep 30, 2021 | -8.36 |
| Jun 30, 2021 | -75.66 |
| Mar 31, 2021 | 3.98 |
| Dec 31, 2020 | -18.76 |